Interestingly, Izar et al. [29] also proposed the activation of IL6 and JAK/STAT in a subgroup of fibroblasts and HGSTOC cancer cells, suggesting it is involved in the pathogenesis of malignant ascites and drug resistance. This evidence concerns the gene IL6 and cancer.